
| Pair Name | Morusin, TNF-related apoptosis inducing ligand | ||
| Phytochemical Name | Morusin (PubChem CID: 5281671 ) | ||
| Anticancer drug Name | TNF-related apoptosis inducing ligand (PubChem CID: / ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Morusin, TNF-related apoptosis inducing ligand | |||
| Disease Info | [ICD-11: 2A00] | Glioblastoma multiforme | Investigative | |
| Biological Phenomena | Induction-->Apoptosis | |||
| Gene Regulation | Up-regulation | Expression | TNFRSF10B | hsa8795 |
| Down-regulation | Expression | BIRC5 | hsa332 | |
| Down-regulation | Expression | XIAP | hsa331 | |
| Down-regulation | Expression | EGFR | hsa1956 | |
| Down-regulation | Phosphorylation | STAT3 | hsa6774 | |
| In Vitro Model | U-251MG | Astrocytoma | Homo sapiens (Human) | CVCL_0021 |
| LN-18 | Glioblastoma | Homo sapiens (Human) | CVCL_0392 | |
| Result | These results suggest that morusin enhances TRAIL sensitivity in human glioblastoma cells through regulating expression of DR5 and EGFR. Therefore, the combination treatment of TRAIL and morusin may be a new therapeutic strategy for malignant glioma patients. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Morusin Induces TRAIL Sensitization by Regulating EGFR and DR5 in Human Glioblastoma Cells. J Nat Prod. 2016 Feb 26;79(2):317-23. doi: 10.1021/acs.jnatprod.5b00919. | Click |